×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 2: Definition of Adaptive Clinical Trials
Session Chair(s)
Sandeep Menon, PhD
Chief Scientific Officer of Artificial Intelligence and Digital Science and SVP,
Pfizer Inc, United States
- FDA and EMA
- Definitions (FDA and EMA) of adaptive design
- General information on what adaptations are
- What’s considered Adaptive Design vs. What’s not
- Components of Adaptive Trial
- Rationale for Adaptive Clinical Trial Designs
- Myths and Myth Busters
- Advantages and Disadvantages
- Exploratory vs. Confirmatory Trials
- What is acceptable at exploratory vs. confirmatory stage